In vitro evaluation of β-carboline alkaloids as potential anti-Toxoplasma agents

BMC Research Notes

Volumn 6, Issue 1, 2013, Pages

  Alomar, Maria L ^a   Rasse Suriani, Federico A O ^a   Ganuza, Agustina ^a   Cóceres, Verónica M ^a   Cabrerizo, Franco M ^a   Angel, Sergio O ^a  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

Author keywords

carbolines; Cell cycle; Drug; Invasion; Toxoplasma gondii

Indexed keywords

PROTOZOA; TOXOPLASMA; TOXOPLASMA GONDII;

ALKALOID; CARBOLINE DERIVATIVE;

ANIMAL; ARTICLE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; IN VITRO STUDY; TOXOPLASMA; TOXOPLASMOSIS;

ALKALOIDS; ANIMALS; CARBOLINES; TOXOPLASMA; TOXOPLASMOSIS;

EID: 84877288247     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-6-193     Document Type: Article

References (44)

1. Toxoplasma gondii: from animals to humans. Tenter AM, Heckeroth AR, Weiss LM, Int J Parasitol 2000 30 12-13 1217 1258 11113252
2. Congenital parasitic infections: a review. Carlier Y, Truyens C, Deloron P, Peyron F, Acta Trop 2012 121 2 55 70 10.1016/j.actatropica.2011.10.018 22085916
3. Obsessive-compulsive disorder and acquired toxoplasmosis in two children. Brynska A, Tomaszewicz-Libudzic E, Wolanczyk T, Eur Child Adolesc Psychiatry 2001 10 3 200 204 10.1007/s007870170027 11596821 (Pubitemid 32904927)
4. Is there any role of Toxoplasma gondii in the etiology of obsessive-compulsive disorder? Miman O, Mutlu EA, Ozcan O, Atambay M, Karlidag R, Unal S, Psychiatry Res 2010 177 1-2 263 265 20106536
5. Toxoplasma and schizophrenia. Yolken RH, Dickerson FB, Fuller Torrey E, Parasite Immunol 2009 31 11 706 715 10.1111/j.1365-3024.2009.01131.x 19825110
6. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Vittecoq M, Elguero E, Lafferty KD, Roche B, Brodeur J, Gauthier-Clerc M, Misse D, Thomas F, Infect Genet Evol 2012 12 2 496 498 10.1016/j.meegid.2012.01.013 22285308
7. Toxoplasmic encephalitis in AIDS. Luft BJ, Remington JS, Clin Infect Dis 1992 15 2 211 222 10.1093/clinids/15.2.211 1520757
8. Biology of Toxoplasma gondii. Wong SY, Remington JS, AIDS 1993 7 3 299 316 10.1097/00002030-199303000-00001 8471191 (Pubitemid 23104544)
9. The development and biology of bradyzoites of Toxoplasma gondii. Weiss LM, Kim K, Front Biosci 2000 5 391 405 10.2741/Weiss 10762601
10. New antibacterials for the treatment of toxoplasmosis; a patent review. Rodriguez JB, Szajnman SH, Expert Opin Ther Pat 2012 22 3 311 333 10.1517/13543776.2012.668886 22404108
11. Toxoplasma histone acetylation remodelers as novel drug targets. Vanagas L, Jeffers V, Bogado SS, Dalmasso MC, Sullivan WJ Jr, Angel SO, Expert Rev Anti Infect Ther 2012 10 10 1189 1201 10.1586/eri.12.100 23199404
12. Angel SO, Matrajt M, Echeverria PC, A review of recent patents on the protozoan parasite HSP90 as a drug target Biotechnol: Recent Pat 2012
13. Guillen H: beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Herraiz T, Gonzalez D, Ancin-Azpilicueta C, Aran VJ, Food Chem Toxicol 2010 48 3 839 845 10.1016/j.fct.2009.12.019 20036304
14. Exposure to beta-carbolines norharman and harman. Pfau W, Skog K, J Chromatogr B Analyt Technol Biomed Life Sci 2004 802 1 115 126 10.1016/j.jchromb.2003.10.044 15036003 (Pubitemid 38224277)
15. Balasubramanian D: beta-carbolines that accumulate in human tissues may serve a protective role against oxidative stress. Pari K, Sundari CS, Chandani S, J Biol Chem 2000 275 4 2455 2462 10.1074/jbc.275.4.2455 10644699 (Pubitemid 30082006)
16. The impact of smoking and drinking on plasma levels of norharman. Spijkerman R, van den Eijnden R, van de Mheen D, Bongers I, Fekkes D, Eur Neuropsychopharmacol 2002 12 1 61 71 10.1016/S0924-977X(01)00143-2 11788242 (Pubitemid 34098832)
17. Simple compounds with high pharmacologic potential: beta-carbolines. Origins, syntheses, biological properties. Torreilles J, Guerin MC, Previero A, Biochimie 1985 67 9 929 947 10.1016/S0300-9084(85)80289-3 3910114 (Pubitemid 16195653)
18. One- and two-photon excitation of beta-carbolines in aqueous solution: pH-dependent spectroscopy, photochemistry, and photophysics. Gonzalez MM, Arnbjerg J, Denofrio MP, Erra-Balsells R, Ogilby PR, Cabrerizo FM, J Phys Chem A 2009 113 24 6648 6656 10.1021/jp902105x 19514786
19. An in vitro evaluation of human DNA topoisomerase I inhibition by Peganum harmala L. seeds extract and its beta-carboline alkaloids. Sobhani AM, Ebrahimi SA, Mahmoudian M, J Pharm Pharm Sci 2002 5 1 19 23 12042115 (Pubitemid 34463347)
20. beta-Carboline alkaloids: biochemical and pharmacological functions. Cao R, Peng W, Wang Z, Xu A, Curr Med Chem 2007 14 4 479 500 10.2174/ 092986707779940998 17305548
21. Synergistic in vitro antimalarial activity of plant extracts used as traditional herbal remedies in Mali. Azas N, Laurencin N, Delmas F, Di GC, Gasquet M, Laget M, Timon-David P, Parasitol Res 2002 88 2 165 171 10.1007/s004360100454 11936507 (Pubitemid 34151146)
22. Antimalarial activity of extracts and alkaloids isolated from six plants used in traditional medicine in Mali and Sao Tome. Ancolio C, Azas N, Mahiou V, Ollivier E, Di Giorgio C, Keita A, Timon-David P, Balansard G, Phytother Res 2002 16 7 646 649 10.1002/ptr.1025 12410545 (Pubitemid 35334185)
23. HPLC quantification of alkaloids from Haplophyllum extracts and comparison with their cytotoxic properties. Fiot J, Jansen O, Akhmedjanova V, Angenot L, Balansard G, Ollivier E, Phytochem Anal 2006 17 5 365 369 10.1002/pca.927 17019939 (Pubitemid 44404621)
24. In vitro activity of the beta-carboline alkaloids harmane, harmine, and harmaline toward parasites of the species Leishmania infantum. Di Giorgio C, Delmas F, Ollivier E, Elias R, Balansard G, Timon-David P, Exp Parasitol 2004 106 3-4 67 74 15172213 (Pubitemid 38686275)
25. Harmine: evaluation of its antileishmanial properties in various vesicular delivery systems. Lala S, Pramanick S, Mukhopadhyay S, Bandyopadhyay S, Basu MK, J Drug Target 2004 12 3 165 175 10.1080/10611860410001712696 15203896 (Pubitemid 38868164)
26. Effects of some beta-carboline alkaloids on intact Trypanosoma cruzi epimastigotes. Rivas P, Cassels BK, Morello A, Repetto Y, Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999 122 1 27 31 10.1016/S0742-8413(98)10069-5 10190025 (Pubitemid 29073358)
27. Heat Shock Protein 90 Inhibitors as Broad Spectrum Anti-infectives. Rochani AK, Singh M, Tatu U, Curr Pharm Des 2012
28. A repurposing strategy identifies novel synergistic inhibitors of Plasmodium falciparum heat shock protein 90. Shahinas D, Liang M, Datti A, Pillai DR, J Med Chem 2010 53 9 3552 3557 10.1021/jm901796s 20349996
29. Harmine is a potent antimalarial targeting Hsp90 and synergizes with chloroquine and artemisinin. Shahinas D, Macmullin G, Benedict C, Crandall I, Pillai DR, Antimicrob Agents Chemother 2012 56 8 4207 4213 10.1128/AAC.00328-12 22615284
30. New manzamine alkaloids with potent activity against infectious diseases. El Sayed KA, Kelly M, Kara UA, Ang KK, Katsuyama I, Dunbar DC, Khan AA, Hamann MT, J Am Chem Soc 2001 123 9 1804 1808 10.1021/ja002073o 11456797 (Pubitemid 32199996)
31. β-Carbolines as specific inhibitors of cyclin-Dependent kinases. Song Y, Wang J, Teng SF, Kesuma D, Deng Y, Duan J, Wang JH, Qi RZ, Sim MM, Bioorg Med Chem Lett 2002 12 7 1129 1132 10.1016/S0960-894X(02)00094-X 11909733 (Pubitemid 34242818)
32. Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine. Song Y, Kesuma D, Wang J, Deng Y, Duan J, Wang JH, Qi RZ, Biochem Biophys Res Commun 2004 317 1 128 132 10.1016/j.bbrc.2004.03.019 15047157 (Pubitemid 38401973)
33. Photochemistry of norharmane in aqueous solution. Gonzalez MM, Salum ML, Gholipour Y, Cabrerizo FM, Erra-Balsells R, Photochem Photobiol Sci 2009 8 8 1139 1149 10.1039/b822173a 19639116
34. Cytotoxicity of the beta-carboline alkaloids harmine and harmaline in human cell assays in vitro. Jimenez J, Riveron-Negrete L, Abdullaev F, Espinosa-Aguirre J, Rodriguez-Arnaiz R, Exp Toxicol Pathol 2008 60 4-5 381 389 18430551
35. Building the perfect parasite: cell division in apicomplexa. Striepen B, Jordan CN, Reiff S, van Dooren GG, PLoS Pathog 2007 3 6 78 10.1371/journal.ppat. 0030078 17604449 (Pubitemid 47015870)
36. Regulation of apicomplexan actin-based motility. Baum J, Papenfuss AT, Baum B, Speed TP, Cowman AF, Nat Rev Microbiol 2006 4 8 621 628 10.1038/nrmicro1465 16845432 (Pubitemid 44317024)
37. Bromal-derived tetrahydro-beta-carbolines as neurotoxic agents: chemistry, impairment of the dopamine metabolism, and inhibitory effects on mitochondrial respiration. Bringmann G, Feineis D, Bruckner R, Blank M, Peters K, Peters EM, Reichmann H, Janetzky B, Grote C, Clement HW, Bioorg Med Chem 2000 8 6 1467 1478 10.1016/S0968-0896(00)00073-0 10896123 (Pubitemid 30398466)
38. Defining the cell cycle for the tachyzoite stage of Toxoplasma gondii. Radke JR, Striepen B, Guerini MN, Jerome ME, Roos DS, White MW, Mol Biochem Parasitol 2001 115 2 165 175 10.1016/S0166-6851(01)00284-5 11420103 (Pubitemid 32566226)
39. Photosensitization of DNA by beta-carbolines: kinetic analysis and photoproduct characterization. Gonzalez MM, Vignoni M, Pellon-Maison M, Ales-Gandolfo MA, Gonzalez-Baro MR, Erra-Balsells R, Epe B, Cabrerizo FM, Org Biomol Chem 2012 10 9 1807 1819 10.1039/c2ob06505c 22249177
40. Photosensitized cleavage of plasmidic DNA by norharmane, a naturally occurring beta-carboline. Gonzalez MM, Pellon-Maison M, Ales-Gandolfo MA, Gonzalez-Baro MR, Erra-Balsells R, Cabrerizo FM, Org Biomol Chem 2010 8 11 2543 2552 10.1039/c002235g 20499453
41. Arrest of replication forks by drug-stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin. Hsiang YH, Lihou MG, Liu LF, Cancer Res 1989 49 18 5077 5082 2548710 (Pubitemid 19239347)
42. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons. D'Arpa P, Beardmore C, Liu LF, Cancer Res 1990 50 21 6919 6924 1698546 (Pubitemid 20361091)
43. Toxoplasma gondii Hsp90 is a potential drug target whose expression and subcellular localization are developmentally regulated. Echeverria PC, Matrajt M, Harb OS, Zappia MP, Costas MA, Roos DS, Dubremetz JF, Angel SO, J Mol Biol 2005 350 4 723 734 10.1016/j.jmb.2005.05.031 15967463 (Pubitemid 40848670)
44. Synthesis and evaluation of beta-carboline derivatives as potential monoamine oxidase inhibitors. Reniers J, Robert S, Frederick R, Masereel B, Vincent S, Wouters J, Bioorg Med Chem 2011 19 1 134 144 10.1016/j.bmc.2010.11. 041 21183355